Who owns the ENDURX PHARMACEUTICALS trademark?

The ENDURX PHARMACEUTICALS trademark is owned by EnduRx Pharmaceuticals, Inc..

What class is the ENDURX PHARMACEUTICALS trademark registered in?

The ENDURX PHARMACEUTICALS trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for ENDURX PHARMACEUTICALS?

The USPTO serial number for ENDURX PHARMACEUTICALS is 86030250.

What is the registration number for ENDURX PHARMACEUTICALS?

ENDURX PHARMACEUTICALS is registered under USPTO registration number 4608315.

END

USPTO Trademark Record

ABANDONED

ENDURX PHARMACEUTICALS

SN 86030250·Reg 4608315·Filed Aug 06, 2013

Owner EnduRx Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

ENDURX PHARMACEUTICALS (Serial No. 86030250), Registration No. 4608315, is a abandoned US trademark filed on Aug 06, 2013 by EnduRx Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

Mark Intelligence

ENDURX PHARMACEUTICALS (Reg. #4608315) is an abandoned US trademark that was filed in 2013 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 06, 2013

SERIAL

86030250

REG#

4608315

REGISTERED

Sep 23, 2014

Owner

Applicant

EnduRx Pharmaceuticals, Inc.

Entity

Corporation

State

Address

Suites 102-270, 4262 Blue Diamond Road, Las Vegas, NV, 89139

Country

Attorney

NameChristopher P. Perkins, Ph.D.

Law firm

CHRISTOPHER P. PERKINS, PH.D. JENKINS, WILSON, TAYLOR & HUNT, P.A.

Docket

1861/8

Address

3100 TOWER BLVD, DURHAM, NC 27707-2563, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateAug 06, 2013

Serial Number86030250

Registration No.4608315

Registration DateSep 23, 2014

Status DateApr 30, 2021

Published for OppositionJul 08, 2014

Mark TypeStandard characters

Attorney Docket1861/8

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2013

YEARS AGO

13y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jul 31, 2011

First use in commerce: Jul 31, 2011

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Jul 31, 2011

First use in commerce: Jul 31, 2011

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

CANCELLED SEC. 8 (6-YR)

Apr 30, 2021

CANCELLED SEC. 8 (6-YR)

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 23, 2019

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Sep 23, 2014

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jul 08, 2014

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 08, 2014

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 18, 2014

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

May 31, 2014

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

May 31, 2014

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 19, 2014

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 16, 2014

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 16, 2014

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 16, 2014

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Nov 21, 2013

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 21, 2013

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 21, 2013

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 19, 2013

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 14, 2013

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 09, 2013

NEW APPLICATION ENTERED

ENDURX PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christopher P. Perkins, Ph.D.

Resources

Company